Real-world treatment patterns and clinical outcomes for patients with relapsed/refractory multiple myeloma who received elranatamab

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Other
• If ‘other’, further details on the scope of the study:
  Real-world evidence

Study drug and medical condition

• Medicinal product name:
  ELREXFIO
• Study drug International non-proprietary name (INN) or common name:
  ELRANATAMAB